ENANTA PHARMACEUTICALS, INC (ENTA)

SEC filing

ENANTA PHARMACEUTICALS, INC

ENTA · CIK 1177648

4 · Dec 3, 2025 · Capps Kathleen S. sold 207 shares at $13.96/share ($2,890); reported 85 shares

Capps Kathleen S. sold 207 shares at $13.96/share ($2,890); reported 85 shares

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

xslF345X05/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).

4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESform4.xml
Open SEC.gov